Exam 1: Dynamics Flashcards

1
Q

Pharmacodynamics

A

study of physiological and biochemical interaction of drug molecules with target tissue that is responsible for ultimate effects of drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Large protein molecules located on cell surface/within cells that are initial sites of action of biological active agents

A

receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Two types of receptors

A

cell surface-extracellular

Intracellular: cytoplasm/nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Most hormones that acat on brain to influence neural events use ___ receptor

A

intracellular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

high affinity

A

attach most readily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

low effiacy

A

can attach, but doesn’t do anything

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

antagonist

A

block effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

agonist

A

act as NT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Partial agonists

A

efficacy less than full agonists, but more than antagonist

-effect, but not as much

Technically some intrinsic activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Inverse agonists

A

initiate biological action, but action is opposite to agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Receptor number modification

A

long term regulation:

up-regulation: increase receptors

down regulation: decrease receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Receptors modified in sensitivity

A

more rapid regulation via 2nd messengers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The idea that receptor proteins have different characteristics in different target tissue

A

receptor subtypes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Does response curve

A

describes the extent of biological/behavioral effect (mean response in population) produced by given [drug]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ED50

A

dose that produces 1/2 maximal effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ED100

A

maximum response occurs at does which we assume receptors fully occupied

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Potency

A

absolute amount of drug necessary to produce a specific effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

maximum on y-axis

A

efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

TD50

A

does at which 50% of the population experiences a particular toxic effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Therapeutic index

A

TI= TD50 / ED50

LD50 / ED 50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Factor index

A

dose of drug that is lethal to 1% of the population compared with the dose that is therapeutically effective in 99% of the population (LD1 / ED99)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Competitive Antagonists

A

can be displaced from sites by excess of agonist because increase [drug] competes more effectively for fixed receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Noncompetitive antagonists

A

drugs that reduce effects of agonists in ways other than competing for the receptor.

e.i. binding to portion of receptor other than agonist binding site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Physiological antagonism

A

two drugs that act in 2 distinct ways but interact in such a way that they reduce each other’s effectiveness in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Potentiation

A

situation in which combo of 2 drugs produces effects that are greater than the sum of their individual effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Radioligand binding

A

used to study number of receptors in given region

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Radioligand: to measure amount of ligand that binds to sites we are concerned with, add

A

very high [nonradioactive competing ligand] to some tubes to show most radioactive binding displaced.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

radioligand: ___ binding subtracted when data for specific binding calculated

A

nonspecific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Saturability

A

finite # receptors in tissue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Point at which binding curve plateus

A

Bmax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

If you compare rate of dissociation with rate of binding, you get ___

A

Kd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Kd

A

dissociation constant, measure of drug affinity for specific receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Autoradiogarphy

A

use radio ligand on slides instead of ground up tissue

shows radio bound ligand and its location, good fro studying effects of brain lesions.

34
Q

In vivo receptor binding

A

shows researcher where particular drug/NT binds in intact animal

35
Q

Dose response curves only show

A

POTENCY

36
Q

Increase potency

A

decrease ED50 (EC50?)

37
Q

Increase potency

A

lower x-axis value

38
Q

Increase efficacy

A

increase Bmax

39
Q

Factors determining drug potency

A

1) Accessibility (kinetics)
2) affinity (dynamics)
3) intrinsic activity (dynamics)

40
Q

affinity

A

drug binds to receptors

quantitative measure of attraction between drug molecules and receptors

41
Q

intrinsic activity

A

cellular response

42
Q

k1

A

D + R –> DR

Rate at which drug ASSOCIATES with receptor

43
Q

k2

A

DR –> D + R

Rate at which drug DISSOCIATES from receptor

44
Q

how do you measure drug affinity?

A

3H radio ligand label

Substitute 3H (tritium) in for hydrogen

Tritium= PNN

45
Q

QNB

A

binds to acetylcholine mucurinic receptors

46
Q

Beta particle emission: radio isotope

A

Tritium PNN unstable, so decays to helium-3 PPN

47
Q

Radioligand receptor binding is…

A

transient, reversible, selective

saturable, displacement

48
Q

increase affinity:
k1 ___
k2 ___

A

k1 fast

k2 slow

49
Q

kd =

A

k2/k1

50
Q

kd (dissociation), how do we determine?

A

saturation experiment

[radioligand] that labeled 50% receptor in sample

51
Q

Ki (inhibition constant), how do we determine?

A

Competition experiment, [drug] that displaces 50% of radio ligand bound in sample

52
Q

Affinity of drug for receptor

A

Kd

53
Q

total number of receptors

A

Bmax

54
Q

Saturation experiment

A

3H ligand
tissue prep
incubation for 1 hour
total binding = Specific binding (SB) +NSB (bound to membrane)

T= total binding 
SB = T - NSB

Y-axis: SRB
x-axis: [radioligand]

55
Q

Increase affinity means ____ Kd

A

lower Kd

56
Q

Competition experiment: radioactive form of drug not available

A

allows direct comparison of affinities of several different drugs

Same as saturation, but now varied amounts of competitor ligand too

y-axis: % SB of RL
x-axis: log [competitor] M

57
Q

increasing affinity

A

decrease KI

58
Q

Intrinsic Activity:

A

activation of cellular activity by drug

59
Q

Agonist

A

increase affinity, mimic NT (similar cell response)

fully/partially stimulate receptors (intrinsic activity)

60
Q

Antagonist

A

Increase affinity, block receptors (no NT response)
no intrinsic activity, don’t stimulate receptors

NO INTRINSIC ACTIVITY

61
Q

Affinity

A

molecular attraction between drug and receptor

62
Q

Intrinsic Activity

A

Activation of Cellular activity by drug

63
Q

Partial + Full agonist

A

weaker than if just full

64
Q

Primary site of drug action

A

synapse

65
Q

3 Ways to remove a transmitter

A

1) Enzymes
2) Reuptake
3) Glial Reuptake

66
Q

Ionotropic Receptors

A

Fast synaptic transmission (ms)
Subunits around central ion
ions go through

67
Q

Ionotropic examples

A

acetylcholine
GABA-A
5-HT3

68
Q

Metabotropic

A

cell surface receptors regulate activity

Slower (s)
peptides
alpha/beta subunits activate effectors

Agonist receptor bind > Gprotein dissociation

PHOSPHORYLATION

69
Q

G sub salpha

A

increase phosphorylation

70
Q

G sub i

A

decrease phosphorylation

71
Q

Metabotropic receptor examples

A

Acetylcholine [M], monoamines, peptides

72
Q

M2/M4

A

Increase K+ influx

Decrease adenylyl cyclase

73
Q

M1/M3/M5

A

increase phosphoinositide

74
Q

What can phosphorylation do?

A
receptor up down regulation
ion channel open/close
Enzyme activation/deactivation
Neurotransmitter release
dendritic growth
cell metabolism
75
Q

Amino acid NT

A

Glutamate GABA Glycine

76
Q

Monoamines

A

Dopamine, Norepinephrine, Epinephrine, and Serotonin

77
Q

Peptides

A

Opioids, Orexin, CRF, BDNF

78
Q

Novel/Gases

A

NO, CO, H2S

79
Q

Purines

A

ATP, Adenosine

80
Q

Catecholamines

A

D, N, E

81
Q

Indoleamine

A

Serotonin